AAAAAA

   
Results: 1-7 |
Results: 7
PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS IN PERIPHERAL-BLOOD HARVESTSOF PATIENTS MOBILIZED WITH RHSCF PLUS RHG-CSF
Authors: BRIDDELL R STONEY G SCHUSTER L KERN B ZILM K GLASPY J SHPALL E LEMAISTRE F MCNIECE IK
Citation: R. Briddell et al., PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS IN PERIPHERAL-BLOOD HARVESTSOF PATIENTS MOBILIZED WITH RHSCF PLUS RHG-CSF, Experimental hematology, 23(8), 1995, pp. 751-751
TREATMENT OF BREAST-CANCER PATIENTS WITH STEM-CELL FACTOR (RHSCF) ANDFILGRASTIM (RHG-CSF) MOBILIZES INCREASED NUMBERS OF MEGAKARYOCYTE PROGENITORS
Authors: BRIDDELL R GLASPY J SHPALL EJ LEMAISTRE F MENCHACA D MCNIECE I
Citation: R. Briddell et al., TREATMENT OF BREAST-CANCER PATIENTS WITH STEM-CELL FACTOR (RHSCF) ANDFILGRASTIM (RHG-CSF) MOBILIZES INCREASED NUMBERS OF MEGAKARYOCYTE PROGENITORS, Experimental hematology, 22(8), 1994, pp. 683-683
PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FROM BREAST-CANCER PATIENTS MOBILIZED WITH STEM-CELL FACTOR (RHSCF) PLUS FILGRASTIM (RHG-CSF) DEMONSTRATE TYPICAL IN-VITRO GROWTH-FACTOR RESPONSIVENESS
Authors: BRIDDELL R STONEY G GLASPY J SHPALL EJ LEMAISTRE F MENCHACA D MCNIECE I
Citation: R. Briddell et al., PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FROM BREAST-CANCER PATIENTS MOBILIZED WITH STEM-CELL FACTOR (RHSCF) PLUS FILGRASTIM (RHG-CSF) DEMONSTRATE TYPICAL IN-VITRO GROWTH-FACTOR RESPONSIVENESS, Experimental hematology, 22(8), 1994, pp. 757-757
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADULTS WITH NON-HODGKINS-LYMPHOMA - A SOUTHWEST-ONCOLOGY-GROUP
Authors: SAEZ R DAHLBERG S APPELBAUM FR HARTSOCK RJ LEMAISTRE F COLTMAN CA FISHER RI
Citation: R. Saez et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADULTS WITH NON-HODGKINS-LYMPHOMA - A SOUTHWEST-ONCOLOGY-GROUP, Hematological oncology, 12(2), 1994, pp. 75-85
CD34-FACTORS PREDICT ENGRAFTMENT POST TRANSPLANTATION( CELLS IN PHERESIS HARVESTS FROM PATIENTS MOBILIZED BY GROWTH)
Authors: MCNIECE I GLASPY J SHPALL EJ LEMAISTRE F MENCHACA D BRIDDELL R
Citation: I. Mcniece et al., CD34-FACTORS PREDICT ENGRAFTMENT POST TRANSPLANTATION( CELLS IN PHERESIS HARVESTS FROM PATIENTS MOBILIZED BY GROWTH), Blood, 84(10), 1994, pp. 10000348-10000348
EFFECTS OF RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR (RHSCF) AND FILGRASTIM (RHG-CSF) ON MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS - PRELIMINARY LABORATORY RESULTS FROM A PHASE-I II STUDY/
Authors: MCNIECE I GLASPY J LEMAISTRE F BRIDDELL R MENCHACA D SHPALL EJ
Citation: I. Mcniece et al., EFFECTS OF RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR (RHSCF) AND FILGRASTIM (RHG-CSF) ON MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS - PRELIMINARY LABORATORY RESULTS FROM A PHASE-I II STUDY/, Blood, 82(10), 1993, pp. 10000084-10000084
FLUCONAZOLE (FLUC) VERSUS LOW-DOSE AMPHOTERICIN-B (AMPHO) FOR THE PREVENTION OF FUNGAL-INFECTIONS IN PATIENTS (PTS) UNDERGOING MARROW TRANSPLANTATION (BMT) - A STUDY OF THE NORTH-AMERICAN BONE-MARROW TRANSPLANT GROUP (NAMTG)
Authors: WOLFF S FAY J STEVENS D HERZIG R BOLWELL B LYNCH J FREYTES C LEMAISTRE F COLLINS R PINEIRO L GREER J STEIN R GOODMAN S ROGERS K DUMMER S
Citation: S. Wolff et al., FLUCONAZOLE (FLUC) VERSUS LOW-DOSE AMPHOTERICIN-B (AMPHO) FOR THE PREVENTION OF FUNGAL-INFECTIONS IN PATIENTS (PTS) UNDERGOING MARROW TRANSPLANTATION (BMT) - A STUDY OF THE NORTH-AMERICAN BONE-MARROW TRANSPLANT GROUP (NAMTG), Blood, 82(10), 1993, pp. 10000425-10000425
Risultati: 1-7 |